Skip to Content

Nymalize Approval History

FDA Approved: Yes (First approved May 10, 2013)
Brand name: Nymalize
Generic name: nimodipine
Dosage form: Oral Solution
Company: Arbor Pharmaceuticals
Treatment for: Subarachnoid Hemorrhage

Nymalize (nimodipine) is a calcium channel blocker indicated to improve neurological outcome following subarachnoid hemorrhage.

Development History and FDA Approval Process for Nymalize

DateArticle
May 13, 2013Approval Arbor Pharmaceuticals Announces FDA Approval of Nymalize

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide